About me
Sophia Lugo is CEO, Chairman, and Co-Founder at Radar Therapeutics, an mRNA therapeutics company based in Berkeley, California. Before Radar, Sophia held strategy and product roles at BGI Genomics’ Health Division and Ventures Incubator, the Boston Consulting Group, the US Surgeon General's Office, and the Bill & Melinda Gates Foundation, where she led COVAX planning efforts and Covid Vaccine Rollout tracking, communications, and real-time strategic response. She received her Bachelor’s from Harvard University, Masters from Tsinghua University, and MBA from Stanford University. Today, she believes exquisite specificity and in vivo programmability are the next frontier for genetic medicines.